Search hospitals > California > Anaheim
Pacific Cancer Medical Center, Inc.
Claim this profileAnaheim, California 92801
Global Leader in Non-Small Cell Lung Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Colorectal Cancer
Conducts research for Leukemia
86 reported clinical trials
2 medical researchers
Summary
Pacific Cancer Medical Center, Inc. is a medical facility located in Anaheim, California. This center is recognized for care of Non-Small Cell Lung Cancer, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia and other specialties. Pacific Cancer Medical Center, Inc. is involved with conducting 86 clinical trials across 71 conditions. There are 2 research doctors associated with this hospital, such as Veena Charu and Ajit Maniam.Area of expertise
1Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
EGFR positive
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Veena CharuPacific Cancer Medical Center4 years of reported clinical research
Studies Lymphoma
Studies Tumors
10 reported clinical trials
22 drugs studied
Ajit ManiamPacific Cancer Medical Center4 years of reported clinical research
Studies Adenocarcinoma
Studies Pancreatic Adenocarcinoma
2 reported clinical trials
7 drugs studied
Clinical Trials running at Pacific Cancer Medical Center, Inc.
Colorectal Cancer
Breast Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Lung Cancer
Follicular Lymphoma
Small Cell Lung Cancer
Cachexia
Anorexia
Lymphoma
Tucatinib + Trastuzumab + Chemotherapy
for Colorectal Cancer
This study is being done to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive colorectal cancer. This study will also determine what side effects happen when participants take this combination of drugs. A side effect is anything a drug does to the body besides treating your disease. Participants in this study have colorectal cancer that has spread through the body (metastatic) and/or cannot be removed with surgery (unresectable). Participants will be assigned randomly to the tucatinib group or standard of care group. The tucatinib group will get tucatinib, trastuzumab, and mFOLFOX6. The standard of care group will get either: * mFOLFOX6 alone, * mFOLFOX6 with bevacizumab, or * mFOLFOX6 with cetuximab mFOLFOX6 is a combination of multiple drugs. All of the drugs given in this study are used to treat this type of cancer.
Recruiting2 awards Phase 3
Onvansertib + Chemotherapy
for Colorectal Cancer
The purpose of this study is to assess 2 different doses of onvansertib to select the lowest dose that is maximally effective, and to assess the safety, efficacy, pharmacokinetics, and pharmacodynamics of onvansertib in combination with FOLFIRI + bevacizumab or FOLFOX + bevacizumab in patients with KRAS or NRAS-mutated metastatic colorectal cancer (CRC) in the first-line setting.
Recruiting1 award Phase 2
Ponsegromab
for Cachexia
This trial tests Ponsegromab, a new drug, on cancer patients who are losing weight and have high GDF 15 levels. The drug aims to lower GDF 15 to improve appetite and reduce weight loss.
Recruiting0 awards Phase 210 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Pacific Cancer Medical Center, Inc.?
Pacific Cancer Medical Center, Inc. is a medical facility located in Anaheim, California. This center is recognized for care of Non-Small Cell Lung Cancer, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia and other specialties. Pacific Cancer Medical Center, Inc. is involved with conducting 86 clinical trials across 71 conditions. There are 2 research doctors associated with this hospital, such as Veena Charu and Ajit Maniam.